207 related articles for article (PubMed ID: 16413960)
1. Multifunctionality of human 17beta-hydroxysteroid dehydrogenases.
Moeller G; Adamski J
Mol Cell Endocrinol; 2006 Mar; 248(1-2):47-55. PubMed ID: 16413960
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5.
Lin SX; Shi R; Qiu W; Azzi A; Zhu DW; Dabbagh HA; Zhou M
Mol Cell Endocrinol; 2006 Mar; 248(1-2):38-46. PubMed ID: 16480815
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of human 17beta-hydroxysteroid dehydrogenases.
Lukacik P; Kavanagh KL; Oppermann U
Mol Cell Endocrinol; 2006 Mar; 248(1-2):61-71. PubMed ID: 16414178
[TBL] [Abstract][Full Text] [Related]
4. Integrated view on 17beta-hydroxysteroid dehydrogenases.
Moeller G; Adamski J
Mol Cell Endocrinol; 2009 Mar; 301(1-2):7-19. PubMed ID: 19027824
[TBL] [Abstract][Full Text] [Related]
5. Perspectives in understanding the role of human 17beta-hydroxysteroid dehydrogenases in health and disease.
Meier M; Möller G; Adamski J
Ann N Y Acad Sci; 2009 Feb; 1155():15-24. PubMed ID: 19250188
[TBL] [Abstract][Full Text] [Related]
6. Design and validation of specific inhibitors of 17beta-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis.
Day JM; Tutill HJ; Purohit A; Reed MJ
Endocr Relat Cancer; 2008 Sep; 15(3):665-92. PubMed ID: 18541621
[TBL] [Abstract][Full Text] [Related]
7. 17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development.
Marchais-Oberwinkler S; Henn C; Möller G; Klein T; Negri M; Oster A; Spadaro A; Werth R; Wetzel M; Xu K; Frotscher M; Hartmann RW; Adamski J
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):66-82. PubMed ID: 21193039
[TBL] [Abstract][Full Text] [Related]
8. Zebrafish 17beta-hydroxysteroid dehydrogenases: an evolutionary perspective.
Mindnich R; Adamski J
Mol Cell Endocrinol; 2009 Mar; 301(1-2):20-6. PubMed ID: 19111899
[TBL] [Abstract][Full Text] [Related]
9. Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD.
Shafqat N; Marschall HU; Filling C; Nordling E; Wu XQ; Björk L; Thyberg J; Mårtensson E; Salim S; Jörnvall H; Oppermann U
Biochem J; 2003 Nov; 376(Pt 1):49-60. PubMed ID: 12917011
[TBL] [Abstract][Full Text] [Related]
10. Subcellular localization and membrane topology of 17β-hydroxysteroid dehydrogenases.
Tsachaki M; Odermatt A
Mol Cell Endocrinol; 2019 Jun; 489():98-106. PubMed ID: 30864548
[TBL] [Abstract][Full Text] [Related]
11. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
12. Differential androgen and estrogen substrates specificity in the mouse and primates type 12 17beta-hydroxysteroid dehydrogenase.
Blanchard PG; Luu-The V
J Endocrinol; 2007 Aug; 194(2):449-55. PubMed ID: 17641292
[TBL] [Abstract][Full Text] [Related]
13. Two homologous fungal carbonyl reductases with different substrate specificities.
Kristan K; Brunskole M; Stojan J; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):295-302. PubMed ID: 18973748
[TBL] [Abstract][Full Text] [Related]
14. Evolution of 17beta-hydroxysteroid dehydrogenases and their role in androgen, estrogen and retinoid action.
Baker ME
Mol Cell Endocrinol; 2001 Jan; 171(1-2):211-5. PubMed ID: 11165032
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in 17beta-hydroxysteroid dehydrogenases.
Prehn C; Möller G; Adamski J
J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):72-7. PubMed ID: 19444936
[TBL] [Abstract][Full Text] [Related]
16. 17beta-hydroxysteroid dehydrogenases in human breast cancer.
Nagasaki S; Miki Y; Akahira J; Suzuki T; Sasano H
Ann N Y Acad Sci; 2009 Feb; 1155():25-32. PubMed ID: 19250189
[TBL] [Abstract][Full Text] [Related]
17. Human 17beta-hydroxysteroid dehydrogenases types 1, 2, and 3 catalyze bi-directional equilibrium reactions, rather than unidirectional metabolism, in HEK-293 cells.
Khan N; Sharma KK; Andersson S; Auchus RJ
Arch Biochem Biophys; 2004 Sep; 429(1):50-9. PubMed ID: 15288809
[TBL] [Abstract][Full Text] [Related]
18. 17beta-Hydroxysteroid dehydrogenase type 9 and other short-chain dehydrogenases/reductases that catalyze retinoid, 17beta- and 3alpha-hydroxysteroid metabolism.
Napoli JL
Mol Cell Endocrinol; 2001 Jan; 171(1-2):103-9. PubMed ID: 11165018
[TBL] [Abstract][Full Text] [Related]
19. The role of 17 beta-hydroxysteroid dehydrogenases.
Mindnich R; Möller G; Adamski J
Mol Cell Endocrinol; 2004 Apr; 218(1-2):7-20. PubMed ID: 15130507
[TBL] [Abstract][Full Text] [Related]
20. Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.
Aka JA; Mazumdar M; Lin SX
Mol Cell Endocrinol; 2009 Mar; 301(1-2):183-90. PubMed ID: 19038308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
